Bandaram Pharma Packtech Stock Screener | Share Price & Fundamental Analysis

BANDARAM Healthcare Service Provider
Share Price BSE
₹28.00
▼ -0.11 (-0.39%)
2026-04-13 00:00:00
As of April 13, 2026, the Bandaram Pharma Packtech share price (BSE: BANDARAM) is ₹28.00, down 0.39% from the previous close, with shares trading between ₹27.97 and ₹28.19, and a 52-week range of ₹22.88–₹47.52. Browse Bandaram Pharma Packtech annual reports to support your investment research. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Bandaram Pharma Packtech Market Cap ₹50.68 Cr.
BANDARAM P/E Ratio (TTM) 81.76
Bandaram Pharma Packtech P/B Ratio 1.96
EPS (TTM) ₹0.83
Dividend Yield 0.25%
Debt to Equity 1.18
BANDARAM 52 Week High ₹47.52
Bandaram Pharma Packtech 52 Week Low ₹22.88
Operating Margin 6.00%
Profit Margin -
BANDARAM Revenue (TTM) ₹9.00
EBITDA ₹1.00
Net Income -
Total Assets ₹39.00
Total Equity ₹16.00

Bandaram Pharma Packtech Share Price History - Stock Screener Chart

Screen BANDARAM historical share price movements with interactive charts. Analyze price trends and patterns.

Bandaram Pharma Packtech Company Profile - Fundamental Screener

Screen Bandaram Pharma Packtech company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for BANDARAM shares.
Sector Healthcare Services
Industry Healthcare Service Provider
Sub-Sector Healthcare Service Provider
Segment E
ISIN INE875N01036

Bandaram Pharma Packtech Balance Sheet Screener

Screen BANDARAM balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
Item 2025 2024 2023
Assets
Total Assets 39 32 20
Current Assets 31 26 15
Fixed Assets 4 5 5
Liabilities
Total Liabilities 0 0 0
Current Liabilities 9 5 8
Non-Current Liabilities 0 0 0
Shareholders' Equity
Total Equity 16 15 5
Share Capital 12 12 3
Reserves & Surplus 1 0 0

Bandaram Pharma Packtech Income Statement Screener - Profit & Revenue Analysis

Screen Bandaram Pharma Packtech income statement and profit fundamentals. Analyze BANDARAM quarterly results, revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Bandaram Pharma Packtech share price evaluation.
Item 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Mar 2024-Jun 2024-Sept 2024-Dec 2023-Mar 2023-Jun 2023-Sept 2023-Dec 2022-Mar 2022-Jun 2022-Sept
Revenue 9 8 14 15 14 11 7 10 10 6 7 7 0 1 2
Expenses 8 8 13 14 13 11 6 9 10 5 7 7 0 1 2
EBITDA 1 1 1 1 1 1 1 1 1 1 1 1 0 0 0
Operating Profit % 6.00% 8.00% 3.00% 7.00% 5.00% 5.00% 15.00% 7.00% 4.00% 9.00% 6.00% 6.00% 0.00% -5.00% 4.00%
Depreciation 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Interest 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 0 0 0 1 0 0 1 0 0 0 0 0 0 0 0
Tax 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Net Profit 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0
EPS 0.13 0.02 0.03 0.11 0.16 0.15 0.31 -0.01 0.57 0.57 0.05 0.05 -0.03 -0.56 -0.85

Bandaram Pharma Packtech Cash Flow Screener - Liquidity Fundamentals

Screen BANDARAM cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
Item 2025-March 2024-March 2023-March
Operating Activities -5 -4 -1
Investing Activities 0 -2 -5
Financing Activities 5 6 5
Net Cash Flow 0 0 -2

Bandaram Pharma Packtech Shareholding Pattern Screener

See Bandaram Pharma Packtech shareholding pattern with promoter, FII, and DII holdings. Check Bandaram Pharma Packtech promoter holding and ownership changes for BANDARAM on TickJournal.
Item 2025-Mar 2025-Jun 2025-Sept 2025-Nov 2025-Dec 2024-Mar 2024-Jun 2024-Sept
Promoter Holding 75.00% 75.00% 75.00% 62.62% 62.62% 75.00% 75.00% 75.00%
FII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
DII Holding 0.01% 0.01% 0.00% 0.00% 0.00% 0.01% 0.01% 0.01%
Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 23.74% 23.74% 23.75% 36.52% 36.27% 24.21% 24.23% 23.99%
Other Holding 1.25% 1.25% 1.25% 0.86% 1.11% 0.78% 0.76% 1.00%
Shareholder Count 4,827 4,889 4,955 5,004 5,095 4,337 4,425 4,634

Bandaram Pharma Packtech Share Dividend Screener - Share Yield Analysis

Check Bandaram Pharma Packtech dividend history with payout and yield data. View Bandaram Pharma Packtech dividend details including ex-dates and amounts for BANDARAM stock.
Period Dividend Per Share Dividend Yield
2026-March ₹0.00 0.00%
2025-March ₹0.10 0.42%
2024-March ₹0.10 0.22%
2023-March ₹0.10 0.27%
2022-March ₹0.00 0.00%
2021-March ₹0.00 0.00%
2020-March ₹0.00 0.00%
2019-March ₹0.00 0.00%
2018-March ₹0.00 0.00%
2017-March ₹0.00 0.00%

Bandaram Pharma Packtech Stock Index Membership

See which indices include Bandaram Pharma Packtech stock. Check BANDARAM index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Bandaram Pharma Packtech is not part of any tracked indices.
Only major market indices are tracked in our system.

Bandaram Pharma Packtech Market Events Screener - Corporate Actions

Get Bandaram Pharma Packtech corporate actions including splits, bonuses, and buybacks. Check Bandaram Pharma Packtech stock events that may affect BANDARAM share price.
Announcement Date Record Date Event Type Information Price Impact
Annual General Meeting NA 30.87%
Annual General Meeting NA -5.93%
Dividend ₹ 0.10 /share -63.65%
Dividend ₹ 0.10 /share -8.75%
Dividend ₹ 0.10 /share -1.88%
2026-04-27 2026-04-27 Extraordinary General Meeting NA 12.13%
2026-02-13 2026-02-13 Quarterly Result Announcement NA 18.08%
2025-11-13 2025-11-13 Quarterly Result Announcement NA 12.36%
2025-08-14 2025-08-14 Quarterly Result Announcement NA 0.90%
2025-07-21 2025-07-21 Extraordinary General Meeting NA -3.81%
2025-05-30 2025-05-30 Quarterly Result Announcement NA -2.70%
2025-03-14 2025-03-14 Extraordinary General Meeting NA 17.27%
2025-02-14 2025-02-14 Quarterly Result Announcement NA -0.80%
2024-11-14 2024-11-14 Quarterly Result Announcement NA -10.02%
2024-01-12 2024-01-12 Extraordinary General Meeting NA 4.99%

Bandaram Pharma Packtech Competitors Screener - Peer Comparison

Screen BANDARAM competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Dr. Lal Path Labs 23,536 43.86 2,555 11.28% 492 60.71
Vijaya Diagnostic Centre 10,102 62.74 700 23.06% 144 62.23
Metropolis Healthcare 9,705 56.01 1,346 10.64% 146 58.88
Thyrocare Technologies 6,351 45.95 702 20.80% 91 60.09
Nephrocare Health Services 5,622 77.63 770 33.97% 67 56.24
Krsnaa Diagnostics 1,933 24.00 743 16.70% 78 50.38
Suraksha Diagnostic 1,433 41.99 256 15.11% 31 60.86
One Global Service Provider 1,165 17.94 148 134.60% 19 52.94
3B BlackBio DX 1,045 17.73 112 28.72% 48 44.85
Sastasundar Ventures 856 29.59 1,171 -18.47% -134 43.80

Bandaram Pharma Packtech Company Announcements - News Screener

Screen BANDARAM latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
Date Update Actions
2026-04-13 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-04-05 Extra Ordinary General Meeting To Be Held On 27.04.2026 -
2026-04-05 Board Meeting Outcome for Outcome Of Board Meeting To Be Held On 03.04.2026 -
2026-03-27 Closure of Trading Window -
2026-02-16 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-02-13 Board Meeting Outcome for Outcome Of Board Meeting Held On 13.02.2026 -
2026-02-13 Unaudited Financial Results For The Quarter And Nine Months Ended 31.12.2025 -
2026-02-03 Board Meeting Intimation for Meeting To Be Held On 13-02-2026. -
2026-01-30 Announcement under Regulation 30 (LODR)-Change in Management -
2026-01-30 Board Meeting Outcome for Outcome Of Board Meeting Held On 30.01.2026 -
2026-01-10 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2025-12-26 Closure of Trading Window -
2025-12-02 Clarification On Price Movement -
2025-12-02 Clarification sought from Bandaram Pharma Packtech Ltd -
2025-11-13 Board Meeting Outcome for Outcome Of Board Meeting Held On 13.11.2025 -
2025-11-13 Unaudited Financial Results (Standalone And Consolidated) For The Quarter And Half Year Ended 30.09.2025 -
2025-11-08 Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 -
2025-11-07 Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 -
2025-11-07 Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 -
2025-11-07 Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 -